TY  - CONF 
AU  - Firvida  Perez, Jose Luis
AU  - Lazaro Quintela, Martín
AU  - Vázquez Estévez, Sergio
AU  - Varela Ferreiro, Silvia
AU  - Campos Balea, Begoña
AU  - Senin Estor, Clara
AU  - Grande Ventura, Carlos
AU  - Huidobro Vence, Gerardo
AU  - Villanueva Silva, María José
AU  - García Cid, Noelia
PY  - 2013
SN  - 0959-8049
UR  - http://hdl.handle.net/20.500.11940/2314
LA  - eng
TI  - Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study
VL  - 49
ER  -